Total Revenues of Rs. 1,531 million up by 16.2%, EBITDA of Rs. 312 million with margins of 20.4% Performance backed…
Sales up by 9% and 23% for Q3 and 9M FY22, respectively Hester Biosciences Limited announced the financial results of…
EBITDA at INR 1,217 mn, up 13.5% YoY PAT stood at INR 1,008 mn, up 11.8% YoY Mumbai, January 29,…
Continued pressure on US business offsets robust India performance Revenues & profitability: Revenue at 2,108 crores up by 6% Gross…
Revenue for Q2 FY22 of INR 3,520 Million, a growth of 42.0% (y-o-y) and 8.9% (q-o-q) and for H1 FY22…
India operations revenue up by 84% to Rs. 550 Crs. and EBITDA up by 460% to Rs. 71 Crs. Y-o-Y …
Company recommends dividend of 15% - Rs. 1.5 per share for FY 21 Net Revenues from operations in Q4FY21 at…
New Delhi, February 03, 2021: Net revenues in Q3 FY21 at Rs. 113.26 crore, up 15.56 % from Rs. 98.01…
Max Healthcare plays a significant role in combating Covid 19 in Delhi and Mumbai. Treats over 8,000 Covid patients, pioneers…
New Delhi, August 31, 2020: Highlights: Q1’fy 2020-21 (Consolidated) Performance at a Glance (Rs. in Crores) Particulars Q1’FY 2020-21 Q1’FY 2019-20…